24/7 Customer Support

Talk to Clare

+1 339 368 6001

Publication dates

Melanoma Industry, February 2015 Market Reports from Top Publishers

You might be interested in: cancer, breast cancer, colorectal cancer, leukemia, lymphoma, medical equipment, pancreatic cancer, prostate cancer, therapeutics, cancer drug, drug, cancer immunotherapy, genomic health, immunotherapy, dermatology.


 
1-10 of about 100 reports for Melanoma

Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the ...

Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Melanoma Drug Pathway Analyzer 2015

Melanoma Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 303 targeted molecular therapies known to affect more than 251 specific intracellular signaling pathways ...

Key Pharma News 05 JANUARY 2015

Key Pharma News 05 JANUARY 2015

  • $ 1 415
  • Industry report
  • January 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - AbbVie HCV Approval Places Pressure On Gilead To Change Attitude To Drug Pricing Industry Trend Analysis - Diagnostics Gaining Wider Utility In The Pharmaceutical Market Industry ...

Melanoma Drug Pipeline Update 2015

Melanoma Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Melanoma comprises just 5% of all skin cancers but it is the most deadly. High unmet needs still persist for this tumor type and despite three decades of extensive R&D, five-year survival of advanced patients ...

Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies

Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies

  • $ 3 900
  • Industry report
  • December 2014
  • by Firstword Pharma

As the cancer drug market continues to face significant challenges in an environment of rising R&D costs, value-based pricing, demands for real world evidence and tougher regulation, the role of Medical ...

Key Pharma News 01 DECEMBER 2014

Key Pharma News 01 DECEMBER 2014

  • $ 1 415
  • Industry report
  • December 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Merck KGaA/Pfizer Alliance Is Strategic Move For Both In Immuno-Oncology Industry Trend Analysis - CAR-T Therapy Arena Heats Up With Another Biotech Collaboration Industry Trend ...

Genoptix, Inc. (Symbol:GXDX) SWOT Analysis, Strategy, Revenues and Profits

Genoptix, Inc. (Symbol:GXDX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Nevada Cancer Institute SWOT Analysis, Strategy, Revenues and Profits

Nevada Cancer Institute SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

PDS Biotechnology Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PDS Biotechnology Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary PDS Biotechnology Corporation (PDS) is a biotechnology company. It develops and commercializes novel therapies for the prevention of cancer and infectious diseases. The company offers therapies ...

About 1 400 reports for Melanoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the UK

  • August 2013
    20 pages
  • Melanoma  

    Cancer  

  • United Kingdom  

    Europe  

    World  

View report >

4 Companies for Melanoma

Read our Company Profiles

Eli Lilly and Co.

United States

GlaxoSmithKline P.L.C.

United States

Lilly and Co.

United States

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.